Filing Details
- Accession Number:
- 0001181431-13-059672
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-19 17:26:23
- Reporting Period:
- 2013-11-15
- Filing Date:
- 2013-11-19
- Accepted Time:
- 2013-11-19 17:26:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1562195 | Carl Lamm | 4698 Willow Road Pleasanton CA 94588 | Vp Of Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-11-15 | 1,403 | $16.37 | 17,443 | No | 4 | F | Direct | |
Common Stock | Disposition | 2013-11-18 | 2,347 | $15.41 | 15,096 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the number of shares withheld by and surrendered to the Issuer on November 15, 2013, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU grant on November15, 2012 of 15,000 shares. The initial grant vested 25% on November 15, 2013 and the remaining shall vest annually at a rate of 25% per year, subject to the Report Person's continued service to the Issuer.
- The sales reported in this FORM 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 29, 2013.
- The initial RSU grant for 15,000 shares vest in four equal annual installments, of which the first installment vested on November 15, 2013.
- The price reported in Column for is an average price. These shares were sold in multiple transactions at prices ranging from $15.31-$15.52 inclusive. The Reporting Person undertakes to provide to ZELTIQ Aesthetics, Inc., any security holder of ZELTIQ Aesthetics, inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this FORM 4.